| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | US20020099216 Compounds useful in therapy |
| 07/25/2002 | US20020099209 Dihydrostilbene alkanoic acid derivatives |
| 07/25/2002 | US20020099207 Has activity as an antagonist to neurokinin 1 receptors; for therapy of benign prostatic hyperplasia (BPH) |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099092 For therapy of neurological conditions, e.g. epilepsy and pain |
| 07/25/2002 | US20020099079 Treating psoriasis, ulcers, gastroesophageal reflux and conditions caused by gastric hypersecretion including Zollinger-Ellison Syndrome, by administering hydroxylansoprazole or salt |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099047 Oxazepine derivatives and medicine containing the same |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098199 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences |
| 07/25/2002 | US20020098197 Hla binding peptides and their uses |
| 07/25/2002 | US20020098195 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 07/25/2002 | US20020098177 17867, a novel human aminopeptidase |
| 07/25/2002 | DE10102944A1 Production of 3-cyano-1H-indol-7-yl)-(4-(4-fluorophenethyl)piperazin-1-yl)-methanone useful as a selective 5-HT2A antagonist comprises use of an indolecarboxylic acid ester as the starting material |
| 07/25/2002 | DE10056059A1 Differenzierung auslösende Substanzen Differentiation-inducing substances |
| 07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435141A1 Compositions for prevention or treatment of hepatopathy |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2434866A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434490A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | CA2434350A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 07/25/2002 | CA2434296A1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433835A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432776A1 Isoindolyl and isoquinolinyl aroyl pyrrole compounds |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224932A1 Drugs inhibiting cell death |
| 07/24/2002 | EP1224931A1 Use of alkanoyloxymethyl esters for inhibiting histone deacetylase |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224210A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223935A1 Methods of use of fluoroquinolone compounds against bacteria |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223925A2 Use of a fatty acid derivative for the treatment of external secretion disorders |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP1032408B1 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 07/24/2002 | EP0938316B1 Galenic composition containing opioid antagonists |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360022A Recombinant human epidermal growth factor and its preparing process and medicinal composition |
| 07/24/2002 | CN1359727A Medicinal composition containing hepatitis B-resistant transfer factor and Lamivudine |
| 07/24/2002 | CN1359705A 'Hepatitis B and Australia antigen' pill and its preparing process |
| 07/24/2002 | CN1359697A Process for preparing liver-protecting liquor |
| 07/24/2002 | CN1359685A Medicine for treating gastrosis and enteropathy and its preparing process |
| 07/24/2002 | CN1359680A Prescription of preparing moxapride citrate |
| 07/24/2002 | CN1087952C Method for producing medicine for curing vertigo |
| 07/24/2002 | CN1087942C Health-care medicinal liquor for treating diseases of digestive system and method for preparing same |
| 07/23/2002 | US6423728 Heterocyclic thioamide derivatives |
| 07/23/2002 | US6423714 Cyclohexene derivatives useful as antagonists of the motilin receptor |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423340 Gastrointestinal disorders, crohn's colitis |
| 07/23/2002 | US6423300 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2060560C Method for insuring adequate intracellular glutathione in tissue |
| 07/23/2002 | CA2041594C Pyrido[2,3-f][1,4]thiazepines and pyrido[3,2-b][1,5]benzothiazepines |
| 07/18/2002 | WO2002056010A2 Methods for the treatment of ibs |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055692A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease |